Form D · Pharmaceuticals
Burke Therapeutics, LLC
Hot Springs, AR · CIK 0001720847
Offering snapshot reported Nov 5, 2019 · SEC filing
- Reported sold
- $250K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 21, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 5, 2019 | Initial | $250,000 | No comparison | 3 | SEC filing |
| Oct 26, 2017 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 04, 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-352558
Limited interest in profits
None
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Nov 5, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Leon Lewis | Executive |
| Angela Colleen Sutter | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3363 Central Avenue, Suite I
Hot Springs, AR, 71913
Hot Springs, AR, 71913